Awiqli Once Weekly Basal Insulin in India: Novo Nordisk Launches Revolutionary Diabetes Treatment
Awiqli once weekly basal insulin in India marks a major breakthrough in diabetes care. Learn about Novo Nordisk’s insulin icodec, its benefits, key facts, historical background, FAQs, and exam-oriented points for UPSC, SSC, Banking, Railways, Defence, and State PSC exams. A Major Milestone in India’s Diabetes Care Global pharmaceutical company Novo Nordisk has launched Awiqli…
